Inovio Pharmaceuticals, Inc. (NASDAQ:INO – Get Free Report) was the target of a significant increase in short interest in March. As of March 15th, there was short interest totalling 2,060,000 shares, an increase of 10.8% from the February 29th total of 1,860,000 shares. Based on an average trading volume of 526,600 shares, the short-interest ratio […]
StockNews.com upgraded shares of Inovio Pharmaceuticals (NASDAQ:INO – Free Report) from a sell rating to a hold rating in a report released on Monday. Several other research analysts have also weighed in on the company. Oppenheimer upgraded Inovio Pharmaceuticals from a market perform rating to an outperform rating and set a $4.00 target price on […]
Inovio Pharmaceuticals (NASDAQ:INO – Get Free Report) was downgraded by research analysts at StockNews.com from a “hold” rating to a “sell” rating in a note issued to investors on Friday. A number of other research firms also recently weighed in on INO. JMP Securities started coverage on Inovio Pharmaceuticals in a report on Thursday, January […]
Inovio Pharmaceuticals, Inc. (NASDAQ:INO – Get Free Report) saw a large decrease in short interest in January. As of January 15th, there was short interest totalling 22,510,000 shares, a decrease of 5.8% from the December 31st total of 23,890,000 shares. Based on an average daily volume of 3,570,000 shares, the short-interest ratio is currently 6.3 […]
StockNews.com upgraded shares of Inovio Pharmaceuticals (NASDAQ:INO – Free Report) from a sell rating to a hold rating in a report released on Thursday morning. INO has been the topic of several other research reports. JMP Securities began coverage on Inovio Pharmaceuticals in a research report on Thursday, January 4th. They set a market outperform […]